The incidence of EGFR mutations in advanced stage NSCLC varies among different ethnicities, of which highest prevalence is observed among Asians (Benbrahim et al. 2018; Melosky et al. 2022; Hofman et al. 2023). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.